Prostate-specific antigen.

Abstract:

:Prostate specific antigen (PSA) is serine protease produced at high concentrations by normal and malignant prostatic epithelium. It is mainly secreted into seminal fluid, where it digests the gel forming after ejaculation. Only minor amounts of PSA leak out into circulation from the normal prostate, but the release of PSA is increased in prostatic disease. Thus PSA is a sensitive serum marker for prostate cancer but its specificity is limited by a high frequency of falsely elevated values in men with benign prostatic hyperplasia (BPH). Approximately two-thirds of all elevated values (>4 microg/l) in men over 50 years of age are due to BPH. In serum, most of the PSA immunoreactivity consists of a complex between PSA and alpha1-antichymotrypsin (PSA-ACT) whereas approximately 5-40% are free. The proportion of PSA-ACT is larger and the free fraction is smaller in prostate cancer than in benign prostatic hyperplasia (BPH). Determination of the proportion of free PSA has become widely used to improve the cancer specificity of PSA especially in men with PSA values in the 'grey zone' (4-10 microg/l). PSA also occurs in complexes with other protease inhibitors and determination of these and other markers may further improve the diagnostic accuracy for prostate cancer. Interpretation of the results for many different markers is complicated, but this can be simplified by using statistical methods. The diagnostic accuracy can be further improved by using logistic regression or neural networks to estimate the combined impact of marker results and other findings like digital rectal examination (DRE), transrectal ultrasound (TRUS) and heredity.

journal_name

Semin Cancer Biol

authors

Stenman UH,Leinonen J,Zhang WM,Finne P

doi

10.1006/scbi.1998.0086

keywords:

subject

Has Abstract

pub_date

1999-04-01 00:00:00

pages

83-93

issue

2

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(98)90086-4

journal_volume

9

pub_type

杂志文章,评审
  • Genetic dissection of melanoma pathways in the mouse.

    abstract::The frequent loss of the INK4a/ARF locus, encoding for both p16(INK4a)and p19(ARF)in human melanoma, raises the question as to which INK4a/ARF gene product functions to suppress melanoma-genesis in vivo. Studies in the mouse have shown that activated RAS mutation can cooperate with INK4a(Delta 2/3)deficiency (null for...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0376

    authors: Yang FC,Merlino G,Chin L

    更新日期:2001-06-01 00:00:00

  • Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.

    abstract::As stated by Otto Warburg nearly a century ago, cancer is a metabolic disease, a fermentation caused by malfunctioning mitochondria, resulting in increased anabolism and decreased catabolism. Treatment should, therefore, aim at restoring the energy yield. To decrease anabolism, glucose uptake should be reduced (ketoge...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.01.005

    authors: Schwartz L,Seyfried T,Alfarouk KO,Da Veiga Moreira J,Fais S

    更新日期:2017-04-01 00:00:00

  • The bcl-2 gene family.

    abstract::Viability is a fundamental determinant of all cellular functions, and regulation of cell viability is important in shaping tissue differentiation and organism development. The genes in the bcl-2 family can profoundly influence cell viability. In addition to bcl-2, cellular genes in this family include bcl-x, bax, mcl-...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1995.0005

    authors: Craig RW

    更新日期:1995-02-01 00:00:00

  • An update on vitamin D signaling and cancer.

    abstract::A low vitamin D status is associated with an increased risk of various cancers, such as of colon, breast, prostate and hematological cells. The biologically most active vitamin D metabolite 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) is a high affinity ligand of the transcription factor vitamin D receptor (VDR). 1,25(OH)2...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.05.018

    authors: Carlberg C,Muñoz A

    更新日期:2020-05-30 00:00:00

  • Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.

    abstract::Data obtained from cutting-edge research have shown that deregulated epigenetic marks are critical hallmarks of cancer. Rapidly emerging scientific evidence has helped in developing a proper understanding of the mechanisms leading to control of cellular functions, from changes in chromatin accessibility, transcription...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.07.013

    authors: Farooqi AA,Fayyaz S,Poltronieri P,Calin G,Mallardo M

    更新日期:2020-07-30 00:00:00

  • Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.

    abstract::Epigenetic modifications are heritable yet reversible, essential for normal physiological functions and biological development. Aberrant epigenetic modifications, including DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation play a crucial role in cancer progression. In cellular ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.12.006

    authors: Mondal P,Natesh J,Penta D,Meeran SM

    更新日期:2020-12-09 00:00:00

  • Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.

    abstract::The dysregulation of apoptosis is a key step in developing cancers, and mediates resistance to cancer therapy. Commitment to apoptosis is caused by permeabilization of the outer mitochondrial membrane, a process regulated by the interactions between different proteins of Bcl-2 family. Furthermore, Bcl-2 family protein...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.08.008

    authors: Yu L,Liu S

    更新日期:2013-12-01 00:00:00

  • Mitogen-activated protein kinases in hepatocellular carcinoma development.

    abstract::Hepatocellular carcinoma (HCC) is among the most frequently occurring cancers and the leading causes of cancer mortality worldwide. Identification of the signaling pathways regulating liver carcinogenesis is critical in developing novel chemoprevention and targeted therapies. Mitogen-activated protein kinases (MAPKs),...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.10.011

    authors: Min L,He B,Hui L

    更新日期:2011-02-01 00:00:00

  • Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.

    abstract::Angiogenesis plays a pivotal role in cancer progression and is required for tissue invasion and metastasis. Starting with Folkman's initial observations in 1971, basic research continued to shed new molecular insight into this multifaceted process, leading to the development of several anti-angiogenic drugs. To date, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.11.005

    authors: Ricciuti B,Foglietta J,Bianconi V,Sahebkar A,Pirro M

    更新日期:2019-06-01 00:00:00

  • H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells.

    abstract::Histamine is produced from histidine by histidine decarboxylase (HDC) in many cells including normal and malignant lymphocytes. We examined the expression of HDC and the effect of histamine receptor antagonists on the proliferation of a human T cell line, Jurkat and on antigen-driven proliferation of lymphocytes from ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0306

    authors: Radvány Z,Darvas Z,Kerekes K,Prechl J,Szalai C,Pállinger E,Valéria L,Varga VL,Sandor M,Erdei A,Falus A

    更新日期:2000-02-01 00:00:00

  • Emergence and prevention of resistance against small molecule inhibitors.

    abstract::Small molecule inhibitors target specific metabolic pathways in tumor cells and are a promising class of drugs for the treatment of cancers. The best known example is the treatment of chronic myeloid leukemia (CML) with Gleevec. This is a small molecule inhibitor of the Bcr-Abl kinase which has been shown to drive the...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.07.002

    authors: Wodarz D,Komarova NL

    更新日期:2005-12-01 00:00:00

  • The dynamics of natural killer cell tolerance.

    abstract::Natural killer (NK) cells are important mediators of resistance against tumor growth and metastasis. NK cell reactivity is regulated by a balance of signals from activating and inhibitory receptors. While reactivity against tumor cells is beneficial, it is essential that NK cells do not attack normal tissue. The disti...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.07.013

    authors: Johansson MH,Höglund P

    更新日期:2006-10-01 00:00:00

  • Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis.

    abstract::Epstein-Barr virus (EBV)-encoded small RNA (EBER) is the most abundant EBV viral transcript and is used as a target molecule to detect EBV-infected cells in tissues by in situ hybridization. EBER is expected to form double-stranded RNA-like structures. The results of the present study show that EBER contributes to onc...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2011.12.007

    authors: Takada K

    更新日期:2012-04-01 00:00:00

  • Novel functions of interferon-induced proteins.

    abstract::Interferons are important cytokines which regulate antiviral, cell growth, immune modulatory and anti-tumor functions. These pleiotropic effects of interferons are brought about by a large number of cellular proteins, the interferon-inducible proteins. Investigation of the biochemical and cellular activities of some o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0312

    authors: Sen GC

    更新日期:2000-04-01 00:00:00

  • Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.

    abstract::While current treatment regimens for acute leukemia can dramatically improve patient survival, there remains room for improvement. Due to its roles in cell differentiation, cell survival, and apoptotic signaling, modulation of the cyclic AMP (cAMP) pathway has provided a meaningful target in hematological malignancies...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.02.004

    authors: Perez DR,Sklar LA,Chigaev A,Matlawska-Wasowska K

    更新日期:2020-02-07 00:00:00

  • Local delivery of poxvirus vaccines for melanoma.

    abstract::The development of vaccines for melanoma has been accelerated by the identification of melanoma-associated antigens, a better understanding of basic immunologic principles, and the ability to construct complex vectors for immunization. The location and context in which T-cell priming occurs significantly influences th...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2003.09.005

    authors: Hörig H,Kaufman HL

    更新日期:2003-12-01 00:00:00

  • What patents tell us about drug repurposing for cancer: A landscape analysis.

    abstract::Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing fo...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.010

    authors: Mucke HAM

    更新日期:2019-09-20 00:00:00

  • Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

    abstract::Ubiquitination plays a key role in regulating the tumour suppressor p53. It targets p53 for degradation by the 26S proteasome. The ubiquitin pathway also regulates the activity and localisation of p53. Ubiquitination requires ubiquitin-activating and -conjugating enzymes and ubiquitin ligases. In addition, ubiquitinat...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.10.004

    authors: Allende-Vega N,Saville MK

    更新日期:2010-02-01 00:00:00

  • Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy.

    abstract::Angiogenesis, the growth of blood capillaries, is regulated by soluble growth factors and insoluble extracellular matrix (ECM) molecules. Soluble angiogenic mitogens act over large distances to initiate capillary growth whereas changes in ECM govern whether individual cells will grow, differentiate, or involute in res...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Ingber DE

    更新日期:1992-04-01 00:00:00

  • Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.

    abstract::The concept of reverse immune surveillance, first conceived over 12 years ago, described the relationship that existed between germinal center-derived B cell lymphoma cells and the host immune system in SjL/J mice. According to reverse immune surveillance, recognition of tumor cell antigens and a response by the host ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0330

    authors: Ponzio NM,Thorbecke GJ

    更新日期:2000-10-01 00:00:00

  • Growing evidence that several human cancers may originate in utero.

    abstract::Hormone-related cancers may originate in utero. Accumulating evidence is given by animal studies, descriptive epidemiologic data and analytic etiologic studies. Indicators of high levels of endogenous pregnancy hormones, like high birth weight and jaundice in the offspring, are associated with increased risk for breas...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0073

    authors: Ekbom A

    更新日期:1998-08-01 00:00:00

  • PIWI-interacting RNAs in human cancer.

    abstract::P-element-induced wimpy testis (PIWI) interacting RNAs (piRNAs) are a class of small regulatory RNAs mechanistically similar to but much less studied than microRNAs and small interfering RNAs. Today the best understood function of piRNAs is transposon control in animal germ cells, which has earned them the name 'guard...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.08.012

    authors: Lin Y,Zheng J,Lin D

    更新日期:2020-09-01 00:00:00

  • Role of protein phosphatase 2A in Drosophila development.

    abstract::The molecular cloning of protein phosphatase 2A subunits from Drosophila has provided insights into the role this enzyme plays in developmental processes and in cell cycle regulation. The trimeric holoenzyme containing the catalytic, 65-kDa and 55-kDa regulatory subunits appears to be preferentially expressed in proli...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1006/scbi.1995.0032

    authors: Mayer-Jaekel RE,Hemmings BA

    更新日期:1995-08-01 00:00:00

  • Evolving paradigms in multifocal breast cancer.

    abstract::The 7th edition of the TNM defines multifocal breast cancer as multiple simultaneous ipsilateral and synchronous breast cancer lesions, provided they are macroscopically distinct and measurable using current traditional pathological and clinical tools. According to the College of American Pathologists (CAP), the chara...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.07.002

    authors: Salgado R,Aftimos P,Sotiriou C,Desmedt C

    更新日期:2015-04-01 00:00:00

  • Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

    abstract::Cancer, being the most prevalent and resistant disease afflicting any gender, age or social status, is the ultimate challenge for the scientific community. The new generation therapeutics for cancer management has shifted the approach to personalized/precision medicine, making use of patient- and tumor-specific marker...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.023

    authors: Zafar S,Beg S,Panda SK,Rahman M,Alharbi KS,Jain GK,Ahmad FJ

    更新日期:2019-08-20 00:00:00

  • Aberrations in DNA repair pathways in cancer and therapeutic significances.

    abstract::Cancer cells show various types of mutations and aberrant expression in genes involved in DNA repair responses. These alterations induce genome instability and promote carcinogenesis steps and cancer progression processes. These defects in DNA repair have also been considered as suitable targets for cancer therapies. ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.02.005

    authors: Motegi A,Masutani M,Yoshioka KI,Bessho T

    更新日期:2019-10-01 00:00:00

  • Extracellular RNA mediates and marks cancer progression.

    abstract::Different types of RNAs identified thus far represent a diverse group of macromolecules that are involved in the regulation of different biological processes. RNA is generally thought to be localized primarily in the nucleus and cytoplasm; however, some types of RNA have been detected in the extracellular milieu. Thes...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.04.010

    authors: Redzic JS,Balaj L,van der Vos KE,Breakefield XO

    更新日期:2014-10-01 00:00:00

  • System approaches of Weiss and Bertalanffy and their relevance for systems biology today.

    abstract::System approaches in biology have a long history. We focus here on the thinking of Paul A. Weiss and Ludwig von Bertalanffy, who contributed a great deal towards making the system concept operable in biology in the early 20th century. To them, considering whole living systems, which includes their organisation or orde...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2011.05.001

    authors: Drack M,Wolkenhauer O

    更新日期:2011-06-01 00:00:00

  • Pyruvate kinase type M2 and its role in tumor growth and spreading.

    abstract::Proliferating cells and tumor cells in particular express the pyruvate kinase isoenzyme type M2 (M2-PK). Within the tumor metabolome M2-PK regulates the proportions of glucose carbons that are channelled to synthetic processes (inactive dimeric form) or used for glycolytic energy production (highly active tetrameric f...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.04.009

    authors: Mazurek S,Boschek CB,Hugo F,Eigenbrodt E

    更新日期:2005-08-01 00:00:00

  • Mitochondrial ribosomes in cancer.

    abstract::Mitochondria play fundamental roles in the regulation of life and death of eukaryotic cells. They mediate aerobic energy conversion through the oxidative phosphorylation (OXPHOS) system, and harbor and control the intrinsic pathway of apoptosis. As a descendant of a bacterial endosymbiont, mitochondria retain a vestig...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.04.004

    authors: Kim HJ,Maiti P,Barrientos A

    更新日期:2017-12-01 00:00:00